FULGENT GENETICS, INC. Other Non-Current Liabilities
FULGENT GENETICS, INC. (FLGT) had Other Non-Current Liabilities of $8.97 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-07-30
- 2026-06-30: Other Liabilities, Noncurrent $8.97M.
- 2026-03-31: Other Liabilities, Noncurrent $9.37M.
- 2025-12-31: Other Liabilities, Noncurrent $7.62M.
- 2025-09-30: Other Liabilities, Noncurrent $7.56M.
| Period end | Other Liabilities, Noncurrent | Other Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $8.97M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $9.37M 10-Q · filed 2026-05-01 | |
| 2025-12-31 | $7.62M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $7.56M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $5.91M 10-Q · filed 2025-08-01 | |
| 2025-03-31 | $6.12M 10-Q · filed 2025-05-02 | |
| 2024-12-31 | $6.97M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $11.81M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $14.40M 10-Q · filed 2024-08-02 | |
| 2024-03-31 | $13.91M 10-Q · filed 2024-05-03 | |
| 2023-12-31 | $15.08M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $15.76M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $16.60M 10-Q · filed 2023-08-04 | |
| 2023-03-31 | $16.07M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $18.23M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $20.04M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $21.67M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $9.71M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $6.80M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $6.58M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $1.20M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $513.00K 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $582.00K 10-K · filed 2022-02-28 | $14.00K 10-K · filed 2021-03-08 |
| 2018-12-31 | $14.00K 10-K · filed 2020-03-13 | |
| 2018-09-30 | $11.00K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $9.00K 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $6.00K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $6.00K 10-K · filed 2019-03-22 | |
| 2017-09-30 | $5.00K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $2.00K 10-Q · filed 2017-08-14 | |
| 2016-12-31 | $2.00K 10-K · filed 2018-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |